AbbVie is committed to collaborating with health care professionals (HCPs), health care organizations (HCOs) and patient organizations to improve patient health across the globe. Our interactions with HCPs, HCOs and patient organizations are guided by openness and transparency to ensure public trust and confidence. AbbVie supports disclosure of these relationships wherever possible to demonstrate the integrity of our relationships with HCPs, HCOs and patient organizations.
We believe interactions with health care professionals bring value to patient care
HCP/HCO disclosures inside the US
Open payments—Physician Payments Sunshine Act
The US Sunshine Act, also known as the Open Payments—Physician Payments Sunshine Act, was enacted as federal law in 2010 as a component of the Affordable Care Act. The Act requires health care manufacturers, including AbbVie, to track financial transactions with certain health care providers (HCPs) and health care organizations (HCOs) and to disclose those transactions on an annual basis. We support the Act and its goal of providing the public greater visibility into interactions between the health care industry and HCPs to ensure public trust and confidence. To learn more, view our FAQs.
U.S. Centers for Medicare and Medicaid Services (CMS) Open Payments Website
If you have questions on the data contained in the reports, please email TransparencyReporting@abbvie.com.
Allergan acquisition
On May 8, 2020, AbbVie completed its acquisition of Allergan, which is now part of AbbVie. To access Allergan’s payments and transfers of value submitted to CMS, please visit: openpaymentsdata.cms.gov.
To access Allergan HCP / HCO disclosures outside of the US please visit: Click here.
AbbVie HCP/HCO disclosures outside of the US
Information exchanged with Healthcare Professionals (HCPs), Healthcare Organizations (HCOs) and patient organizations leads to newer and better therapies and, most importantly, enhanced care for patients. We believe interactions with healthcare professionals and healthcare organizations are essential to advance patient care, gain insights into unmet medical needs and progress the development of new medicines. Our interactions with HCPs and HCOs are based on trust, transparency and integrity, with a goal of providing the public with greater visibility into these interactions to ensure public trust and confidence. AbbVie engages in a range of activities from clinical research to sponsorships to educational activities to exchange information on how new medicines fit into the patient pathway. By bringing greater transparency to these relationships, AbbVie demonstrates its ongoing commitment to strengthening the basis for future collaboration.
Europe
Transparency throughout our industry is a cornerstone of the pact of trust we have with patients and society. As such, AbbVie is proud to disclose our data on transfers of value to HCPs and HCOs in Europe in accordance with the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code, national laws and regulations and country-specific industry codes. In addition, AbbVie has annually published data regarding the financial support we provide to European Patient Organizations since 2010.
Austria
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Belgium
2018 – Disclosure Data
2019 – Disclosure Data
2020 – Disclosure Data
2021 – Coming Soon
Bosnia & Herzegovina
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Bulgaria
2017 – Disclosure Report, Additional Document
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Croatia
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Cyprus
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Czech Republic
2018 – AIFP Disclosure Data, AIFP Congress Sponsoring
2019 – AIFP Disclosure Data, AIFP Congress Sponsoring
2020 – AIFP Disclosure Data, AIFP Congress Sponsoring
2021 – Coming Soon
Estonia
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Finland
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
France
2018 - Disclosure Data
2019 - Disclosure Data
2020 - Disclosure Data
2021 - Disclosure Data
Germany
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Greece
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Hungary
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Iceland
2018 – Disclosure Data
2019 – Disclosure Data
2020 – Disclosure Data - No Transfers of Value
2021 – Coming Soon
Ireland
2018 – Disclosure Data
2019 – Disclosure Data
2020 – Disclosure Data
2021 – Coming Soon
Italy
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Latvia
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Data, Additional Document
2021 – Coming Soon
Lithuania
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – VVKT Disclosure Data
2020 – IFPA Disclosure Report, Additional Document
2021 – Coming Soon
Luxembourg
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Malta
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Netherlands
2018 – Disclosure Data
2019 – Disclosure Data
2020 – Disclosure Data
2021 – Coming Soon
Norway
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Poland
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Portugal
Disclosure Data*
*Please use Google Chrome to view this link.
Republic of North Macedonia
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Romania
2018 – Disclosure Data
2019 – Disclosure Data
2020 – Disclosure Data
2021 – Coming Soon
Russia
2018 – Disclosure Data
2019 – Disclosure Data
2020 – Disclosure Data
2021 – Coming Soon
Serbia
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Slovakia
2018 – MoH Disclosure Data
2018 – AIFP Disclosure Report, AIFP Additional Document
2019 – MoH Disclosure Data
2019 – AIFP Disclosure Report, AIFP Additional Document
2020 – MoH Disclosure Data
2020 – AIFP Disclosure Report, AIFP Additional Document
2021 – MoH Disclosure Data
2021 – AIFP Disclosure – Coming Soon
Slovenia
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Spain
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Sweden
2018 – Disclosure Data
2019 – Disclosure Data
2020 – Disclosure Data
2021 – Coming Soon
Switzerland
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
Turkey – Data submitted per Ministry of Health requirement
Ukraine
2018 – Disclosure Report, Additional Document
2019 – Disclosure Report, Additional Document
2020 – Disclosure Report, Additional Document
2021 – Coming Soon
United Kingdom
2018 – ABPI Disclosure Data
2019 – ABPI Disclosure Data
2020 – ABPI Disclosure Data
2021 – Coming Soon
EFPIA Disclosure Code—2019 Self-Certification Scheme
Latin America
Brazil (Minas Gerais) - Disclosure Data
Colombia - More information coming soon
Mexico - More information coming soon
Middle East/Africa
Saudi Arabia - Data submitted per the Saudi Food and Drug Authority requirement
European patient organization relationships
AbbVie is committed to making a remarkable impact on patients’ lives and their caregivers. We combine advanced science with a deep knowledge of the patient experience and healthcare systems to help people live better, more productive lives. We pursue learning about patient experiences to understand the issues, concerns and priorities of people affected by disease.
Patient organizations are a source of valuable information and support for patients and their caregivers. We foster patient organization relationships based on mutual trust, respect and goals that reflect AbbVie’s transparent and ethical behavioral standards. Through these relationships, AbbVie contributes to informing patients and caregivers about disease states, treatment options and how to improve quality of life. These partnerships facilitate dialogue between interested parties and help create new, cost-effective health care delivery models.
Annually, AbbVie publishes a list of its financial support of European Patient Organizations. Our publication of the following report demonstrates our commitment to transparent disclosure of our financial relationships with patient organizations.
AbbVie’s 2020 European Patient Organization Report, Additional Document
*Please note that the report includes support values for Belgium, France, Netherlands, Romania, Portugal and Turkey, which are also disclosed as part of their local Transparency legislation.
Serbia – Sponsored Professional Conferences
AbbVie has a long-standing commitment to supporting programs aimed at increasing the understanding of scientific, clinical and health care issues that improve patient care. In the interest of transparency, we are disclosing the following list of professional conferences sponsored by AbbVie.
Sponsored Professional Conferences 2013
Sponsored Professional Conferences 2014
Sponsored Professional Conferences 2015
Sponsored Professional Conferences 2016
Sponsored Professional Conferences 2017
Sponsored Professional Conferences 2018
Sponsored Professional Conferences 2019
Sponsored Professional Conferences 2020
